Nisa Investment Advisors
ONC

Nisa Investment Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Nisa Investment Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71K Hold
6
– – ﹤0.01% 2774
2026
Q1 		$1.78K Buy
+6
New +$1.94K ﹤0.01% 2639

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nisa Investment Advisors's ONC Position: Q2 2026 in Review

Nisa Investment Advisors held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 6 shares worth $1.71K. The position accounts for ﹤0.01% of the portfolio, ranked #2774.

Nisa Investment Advisors first reported a position in ONC in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.78K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Nisa Investment Advisors held 6 shares of BeOne Medicines Ltd worth $1.71K as of Q2 2026.
  • Nisa Investment Advisors left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2774 holding.
  • Nisa Investment Advisors first reported a position in BeOne Medicines Ltd in Q1 2026 and has held it in 2 quarters since.
  • Nisa Investment Advisors's BeOne Medicines Ltd position peaked at $1.78K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.